Oncology Division plays a key role in strengthening cancer treatment by offering a diverse range of oncology and haematology therapies. This division provides advanced pharmaceutical solutions that support the management of various cancers and blood-related disorders. By partnering with healthcare professionals and applying scientific advancements, the Hetero Oncology Division stay committed to improving cancer care and providing access to life-enhancing treatments.